💊Sumitomo Dainippon Pharma Announces an Atypical Antipsychotic LONASEN is Now Available in China 💊Sumitomo Dain Thursday February 1st, 2018By Tokio X'press FDA, Pharmaceutical ds-pharma
💊FDA PHARMA today 💊FDA PHARMA to Wednesday December 6th, 2017By Tokio X'press FDA, Pharmaceutical ds-pharma
💊Sumitomo Dainippon Pharma and Poxel Announce Strategic Partnership for Development and Commercialization of Imeglimin, an Investigational Therapeutic Agent for Type 2 Diabetes, in Japan, China and Eleven Other Asian Countries Tuesday October 31st, 2017By Tokio X'press Pharmaceutical ds-pharma
